As Ireland takes over the Presidency of the Council of the European Union, healthcare is moving further up in Europe’s competitiveness agenda. Alongside ongoing negotiations on the Biotech Act, EU policymakers are seeking to balance innovation, resilience and investment with health equity, affordability and strong public health systems. 

 In this new episode of EU Advantage Healthcare, Grayling Brussels explores the health priorities of the Irish Presidency, the political debates shaping the Biotech Act, the future of supplementary protection certificates (SPCs), the role of artificial intelligence in life sciences, and how upcoming EU budget negotiations could influence Europe’s health and biotech ambitions. 

EU Advantage Health is Grayling Brussels’ podcast exploring the policy choices, legislative developments and political priorities shaping Europe’s healthcare environment. Listen on Spotify and follow @Grayling on LinkedIn for the latest updates, insights and conversations.